Michel Pairet

This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 8 CIPO patents and 6 EPO patents. Top assignees: Boehringer Ingelheim Pharma Gmbh & Co Kg, Boehringer Ingelheim Pharma Kg, Boehringer Ingelheim International Gmbh. Active years: 1999-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Pairet. Retrieved from https://idiyas.com/inventor/michel-pairet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 4)

% Patents Active = 78.6

CIPO Patents = 8

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 377(Granted Patents)

Location History:

Stromberg, DE (2002 - 2004)
Biberach, DE (1999 - 2010)

Company Filing History:

6 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

6 out of 149

Boehringer Ingelheim Pharma Kg

patents

1 out of 1,564

Boehringer Ingelheim International Gmbh

patents

4. 1 out of 197

Boehringer Ingelheim Kg

patents

Years Active: 1999-2010

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7851483 - Medicaments comprising steroids and a novel anticholinergic (2010-12-14),

2. 7776315 - Pharmaceutical compositions based on anticholinergics and additional active ingredients (2010-08-17),

3. 7507745 - Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins (2009-03-24),

4. 7417051 - Medicaments comprising betamimetics and a novel anticholinergic (2008-08-26),

5. 7250426 - Tiotropium-containing pharmaceutical combination for inhalation (2007-07-31),

6. 7244742 - Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic (2007-07-17),

7. 7084153 - Medicaments comprising steroids and a novel anticholinergic (2006-08-01),

8. 6696042 - Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists (2004-02-24),

9. 6630466 - Medicament compositions containing anticholinergically-effective compounds and salmeterol (2003-10-07),

10. 6620438 - Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists (2003-09-16),

11. 6608054 - Pharmaceutical compositions based on anticholinergics and endothelin antagonists (2003-08-19),

12. 6455524 - Medicament compositions based on anticholinergically-effective compounds and beta-mimetics (2002-09-24),

13. 6433027 - Medicament compositions based on tiotropium bromide and formoterol fumarate (2002-08-13),

14. 5942503 - Use of Epinastine for the treatment of pain (1999-08-24),

Title: Michel Pairet – Pioneering Innovator in Pharmaceutical Sciences

Introduction

Michel Pairet is a renowned inventor based in Biberach, Germany, who has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 14 patents, his work has paved the way for groundbreaking advancements in respiratory treatment and therapeutic compositions.

Latest Patents

Among his latest patents, Michel Pairet has developed innovative pharmaceutical compositions that include medicaments comprising steroids and novel anticholinergics. One of his notable inventions includes a pharmaceutical composition that combines an anticholinergic with at least one additional active ingredient, such as corticosteroids, dopamine agonists, PDE-IV inhibitors, NK1-antagonists, endothelin antagonists, antihistamines, and EGFR-kinase inhibitors. These compositions and the processes for their preparation have been specifically tailored for treating respiratory diseases.

Career Highlights

Throughout his career, Michel Pairet has been associated with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim Pharma KG and Boehringer Ingelheim Pharma GmbH & Co. KG. His extensive experience and expertise in drug development have led him to become a pivotal figure in advancing therapeutic solutions.

Collaborations

Michael Pairet has collaborated with notable coworkers such as Michael Paul Pieper and Richard Reichl. These partnerships reflect his commitment to fostering innovation and enhancing the research and development processes in the pharmaceutical sector.

Conclusion

Michel Pairet's contributions to pharmaceutical sciences underscore his role as an influential inventor. With a diverse range of patents and collaborations, he continues to impact the industry significantly, especially in developing effective treatment options for respiratory diseases. His career serves as an inspiration for aspiring inventors and researchers in the field.

Profile summary based on public USPTO records.